Immune Design starts dosing patients in Phase I study of LV305 immuno-oncology agent
US-based Immune Design has started dosing patients in a Phase I clinical study of LV305, an immuno-oncology investigational agent from its DCVex lentiviral vector...
Biotech Stocks Technical Report — Research on Exact Sciences, Anacor Pharma, Cubist Pharma, and Agenus
On Friday, June 06, 2014, the NASDAQ Composite ended at 4,321.40, up 0.59%, the Dow Jones Industrial Average finished the day 0.52% higher at...
State-owned British research institute fund Clinical trial of Airsonett – an innovative Swedish asthma treatment
There are 5 million persons suffering from asthma in Great Britain and despite medication, half a million of these persons have symptoms which limit...
Edge Therapeutics begins enrolment in second cohort of EG-1962 Phase I/II trial for aSAH
US-based biotechnology firm Edge Therapeutics has started enrolling patients in the second group of a multicenter, randomised, controlled, open-label, Phase I/II NEWTON trial of...
The Orphan Drugs Market is set to Rise as a Result of Pharma Companies now Looking to Orphan Drugs as an Essential Revenue Stream...
As of January 2014, the EMA lifted the restriction on providing fee reductions to large companies developing new orphan drugs and the Early Access...
Arena begins Phase Ib trial of APD334 to treat autoimmune diseases
US-based Arena Pharmaceuticals has started dosing patients in an investigational Phase Ib clinical trial of APD334, an oral drug candidate that targets the sphingosine...
Chemistry: Provence Technologies acquires Synprosis
Provence Technologies acquires SynprosisThe acquisition strengthens Provence Technologies’ expertise in its core business of therapeutic chemistry Provence Technologies Group, a specialist fine chemistry research...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...